Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Results

Charles River Labs Beats on EPS, Stock Up 11.3%

The strong EPS performance, exceeding expectations, led to an 11.3% increase in the stock price. Investors reacted positively to the earnings surprise, indicating confidence in the company's financial health. However, the lack of revenue data and future guidance leaves some uncertainty about long-term growth prospects.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.46	N/A	+2.71%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting operational efficiency as a key focus. They remain cautiously optimistic about future performance.

We are pleased with our EPS performance this quarter.

Our focus remains on maintaining operational efficiency.

Charles River Labs Beats on EPS, Stock Up 11.3%

Key numbers

Management commentary

Charles River Laboratories International, Inc.

More earnings this week

Charles River Labs Beats on EPS, Stock Up 11.3%

Key numbers

Management commentary